We compared with GIRK1 gene expression with autocrine motility factor-receptor (AMF-R) gene expression, known as a marker of lymph node metastasis and tumor progression, and we investigated how GIRK1 gene expression is related to tumor progression and prognosis in a series of 72 cases of curatively resected NSCLC. The gene discussed is AMFR; the disease is neoplasm.